Perspectives on the Adoption and Implementation

Perspectives on the Adoption and Implementation of Continuous ManufacturingThis session will include 3 highly regarded experts in the CM for biological molecules. These experts will share perspectives and experiences on the development and potential adoption of CM for large molecules.

Integrated Approach to Semi-Continuous Drug Substance Manufacturing
Mehdi Ghodbane, PhD, Downstream Process Development, Medicinal Science & Technology
GlaxoSmithKline
N-1 Perfusion from Development through GMP Implementation
Gene Schaefer, Senior Director Large Molecule API Development
Janssen
Sanofi’s MA Digitalized Facility, an Ecosystem of the Future
Navin Tiwari, Director, Head of Digital Shop Floor & Automation
Sanofi

Gene Schaefer

Senior Director Large Molecule API Development, Janssen

Appearances